Vitiligo develops when your immune system mistakenly attacks and destroys the cells that produce skin pigment. It is not something you “catch” from another person or from a single event. Instead, it results from a combination of genetic susceptibility, immune system dysfunction, and environmental triggers that together cause pigment-producing cells called melanocytes to die off in patches. Roughly 0.4% to 1% of the global population has vitiligo, and onset follows a bimodal pattern, peaking around age 7 in early-onset cases and around age 40 in late-onset cases.
The Autoimmune Process Behind Pigment Loss
Vitiligo is fundamentally an autoimmune disease. Your immune system, which normally fights infections, turns against the melanocytes in your skin. The key players are a type of white blood cell called CD8+ T cells. These cells identify melanocytes as foreign, latch onto them, and release toxic molecules that kill them directly. At the same time, they release a chemical signal called IFN-γ that ramps up local inflammation and attracts even more immune cells to the area, creating a cycle that widens the damage.
Before the targeted attack begins, other parts of the immune system set the stage. Dendritic cells in the skin capture fragments of melanocyte proteins and present them to T cells, essentially training the immune system to recognize melanocytes as threats. Natural killer cells also contribute by directly destroying melanocytes and by releasing signals that activate additional immune responders. This layered assault, involving multiple types of immune cells working in concert, is why vitiligo patches tend to expand over time once they appear.
Oxidative Stress Weakens Melanocytes First
Even before the immune system launches its attack, melanocytes in people with vitiligo are under unusual chemical stress. Research shows that vitiligo melanocytes are hypersensitive to reactive oxygen species, the damaging byproducts of normal cell metabolism. In healthy skin, cells neutralize these molecules through built-in antioxidant defenses. But in vitiligo, a key protective pathway (the Nrf2 antioxidant system) is impaired, leaving melanocytes vulnerable.
When stressed melanocytes start to malfunction, they release “danger signals,” including misfolded proteins and heat shock proteins. These molecules act like alarms that alert the immune system to a problem. The immune system interprets these signals as evidence of damaged or abnormal cells and mounts a response. So the process often starts with internal cellular stress and then escalates into a full autoimmune attack. This two-step sequence helps explain why vitiligo can seem to appear suddenly after a period of physical or emotional stress.
Genetic Risk Factors
Vitiligo runs in families, though most people with vitiligo have no close relatives with the condition. Variations in over 30 genes have been linked to increased risk. Many of these genes are involved in immune regulation, which makes sense given that vitiligo is an autoimmune disease.
One of the strongest genetic associations involves a gene called HLA-A, specifically the variant HLA-A*02:01. This gene controls how cells display protein fragments on their surface for immune inspection. People who carry the high-risk version of this gene produce more of the HLA-A protein, which means their immune cells are more likely to “see” melanocyte proteins and flag them for destruction. Researchers have pinpointed a specific genetic region about 20,000 base pairs away from the gene itself that acts like a volume dial, turning up HLA-A expression in people with the risk variant.
Having these genetic predispositions does not guarantee you will develop vitiligo. It means your immune system is primed in a way that makes an autoimmune response to melanocytes more likely if the right environmental trigger comes along.
Environmental Triggers That Start the Process
In people who are genetically susceptible, specific external events can set vitiligo in motion. The most well-documented triggers include:
- Psychological stress: Intense or prolonged emotional stress is one of the most commonly reported triggers before a first episode of vitiligo. Stress hormones can increase oxidative damage and alter immune function.
- Skin trauma (Koebner phenomenon): Physical injury to the skin, including cuts, scrapes, surgical wounds, burns, sunburns, tattoos, piercings, and even insect bites, can cause new vitiligo patches to appear at the injury site. Any damage that penetrates both the outer and middle layers of skin can trigger this response.
- Chemical exposure: Contact with certain industrial chemicals and skin-whitening products has been linked to vitiligo onset in predisposed individuals.
- UV radiation: Excessive sun exposure, particularly sunburn, can trigger depigmentation in susceptible skin.
These triggers do not cause vitiligo in people without the underlying genetic and immune predisposition. They act as the spark in someone whose system is already loaded with fuel.
The Role of Nerves in Some Cases
About 10% of vitiligo cases follow a different pattern called segmental vitiligo, where patches appear on only one side of the body in a limited area. This form may involve the nervous system more directly. Chemical messengers released by nerve endings in the skin, including neuropeptide Y and dopamine, can influence local inflammation and melanocyte survival. These nerve-derived signals connect to the immune system through a bidirectional network linking skin nerves, hormonal pathways, and immune cells. Segmental vitiligo tends to start earlier in life, spread for a limited time, and then stabilize, unlike the more common generalized form.
Generalized vs. Segmental Vitiligo
The most common type, generalized (or nonsegmental) vitiligo, causes patches of pigment loss on both sides of the body. It can appear anywhere but often affects the face, hands, and areas around body openings. This form tends to expand gradually over years and is most strongly linked to the autoimmune mechanisms described above.
Segmental vitiligo, making up about 10% of cases, stays confined to one area and one side of the body. It typically progresses for six months to two years and then stops spreading. Because it behaves differently and responds differently to treatment, some researchers consider it a related but distinct condition with a stronger neurological component.
How Vitiligo Is Diagnosed
Diagnosis is primarily visual. A dermatologist examines your skin and reviews your medical history. To see depigmented areas more clearly, especially on lighter skin tones, they may use a Wood’s lamp, a handheld device that emits ultraviolet light and makes vitiligo patches glow bright white against surrounding skin.
Because vitiligo is autoimmune, your doctor may also order blood tests to check for other autoimmune conditions. Thyroid disease is the most common overlap. These blood tests do not diagnose vitiligo itself but help identify related conditions that may need separate treatment.
Why Some People Get It and Others Don’t
Vitiligo is not caused by any single factor. It requires a convergence: genetic variants that predispose your immune system to target melanocytes, melanocytes that are unusually sensitive to oxidative stress, and an environmental event that tips the balance. Two siblings can carry the same risk genes, but only one develops vitiligo because the other never encounters the right combination of triggers. This is why vitiligo can appear at any age and why its onset often surprises people who have no family history of the condition. The genetic risk can be subtle, distributed across dozens of small-effect gene variants rather than a single inherited mutation.

